N-Methyl-3,4-methylenedioxyamphetamine
Showing 1 - 25 of >10,000
Healthy Trial in Basel (3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine,
Recruiting
- Healthy
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Clinical Trial Unit
Dec 7, 2021
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Palbociclib
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jan 13, 2023
Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- +2 more
- Ketamine
- +2 more
-
New Haven, ConnecticutYale University
Jun 26, 2023
Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)
Recruiting
- Depressive Disorder, Major
- +2 more
- Ketamine
- +2 more
-
New Haven, ConnecticutYale University
Aug 8, 2022
Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)
Recruiting
- Metastatic Uveal Melanoma
- Defactinib Hydrochloride
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)
Recruiting
- Rhabdomyosarcoma
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 13, 2022
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,
Recruiting
- Oligometastatic Prostate Carcinoma
- +2 more
- Placebo Administration
- +3 more
-
Decatur, Illinois
- +2 more
Aug 11, 2022
Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)
Active, not recruiting
- Thyroid Cancer
- +2 more
-
Stanford, CaliforniaStanford University
Nov 8, 2022
Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City
Not yet recruiting
- Stage IIC Prostate Cancer AJCC v8
- +2 more
- Biospecimen Collection
- +9 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 3, 2023
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma
- Megestrol Acetate
- Pterostilbene
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
OCD Trial (3,4-Methyl enedioxy methamphetamine, Methamphetamine, Cognitive Behavioral Therapy (CBT))
Not yet recruiting
- Obsessive-Compulsive Disorder
- 3,4-Methyl enedioxy methamphetamine
- +2 more
- (no location specified)
Mar 28, 2023
Aging Trial in Glendale
Withdrawn
- Aging
- (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
- Control
-
Glendale, ArizonaGlencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023
PTSD Trial in Vancouver (Placebo, 3,4-methylenedioxymethamphetamine, Psychotherapy)
Terminated
- Posttraumatic Stress Disorder
- Placebo
- +2 more
-
Vancouver, British Columbia, CanadaOffices of Dr. Ingrid Pacey MBBS FRCP[C]
Jun 14, 2022
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- STAT Inhibitor OPB-111077
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022
Substance Use, Healthy Subjects Trial in Badalona (Methylone, 3,4-methylenedioxymethamphetamine, Placebo)
Active, not recruiting
- Substance Use
- Healthy Subjects
- Methylone
- +2 more
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Aug 4, 2022
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia
Recruiting
- Myelodysplastic Syndrome
- +2 more
- Navitoclax
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023
Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)
Withdrawn
- Recurrent Acute Myeloid Leukemia
- Bosutinib Monohydrate
- +6 more
-
Duarte, CaliforniaCity of Hope Meidcal Center
Jun 7, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)
Not yet recruiting
- Bipolar Disorder
- Cannabidiol
- Placebo
-
Calgary, Alberta, Canada
- +7 more
May 18, 2023
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States
Suspended
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 10, 2022
Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)
Suspended
- Recurrent Acute Myeloid Leukemia
- Enasidenib Mesylate
- Liposome-encapsulated Daunorubicin-Cytarabine
-
Los Angeles, California
- +3 more
Sep 27, 2022